Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Return on Capital Employed: 2014-2024

Historic Return on Capital Employed for RedHill Biopharma (RDHL) over the last 10 years, with Dec 2024 value amounting to 8.71%.

  • RedHill Biopharma's Return on Capital Employed rose 13486.00% to -2.34% in Q2 2023 from the same period last year, while for Jun 2023 it was -2.34%, marking a year-over-year increase of 13486.00%. This contributed to the annual value of 8.71% for FY2024, which is 853.00% up from last year.
  • Latest data reveals that RedHill Biopharma reported Return on Capital Employed of 8.71% as of FY2024, which was up 4,793.10% from 0.18% recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Return on Capital Employed ranged from a high of 8.71% in FY2024 and a low of -0.82% during FY2021.
  • Over the past 3 years, RedHill Biopharma's median Return on Capital Employed value was 1.56% (recorded in 2022), while the average stood at 3.48%.
  • Per our database at Business Quant, RedHill Biopharma's Return on Capital Employed slumped by 200bps in 2021 and then spiked by 853bps in 2024.
  • Over the past 5 years, RedHill Biopharma's Return on Capital Employed (Yearly) stood at 1.18% in 2020, then plummeted by 200bps to -0.82% in 2021, then soared by 238bps to 1.56% in 2022, then slumped by 138bps to 0.18% in 2023, then soared by 853bps to 8.71% in 2024.